Entries by

Cool demonstration that the genetic determinants of Parkinson’s susceptibility and progression are importantly different

By Jamie Talan June 17, 2021 Article in brief Researchers at Harvard Medical School have found unique genetic variants that drive disease progression and could be used to determine which patients will progress to Parkinson’s disease dementia. The findings may help neurologists determine which patients have a more aggressive disease course and shine light on […]

Parkinson’s disease progression linked to five variants

Researchers have uncovered five genetic variants that influence the course of Parkinson’s disease and developed a polygenic score to predict which patients will likely develop dementia related to the disease. Nearly 1 million people in the US are estimated to have Parkinson’s disease, which is marked by tremors, muscle stiffness, and balance issues. The course […]

Webinar: Spotlight on Parkinson’s disease: What’s new in PD treatments

The national patient teleconference/webinar Spotlight on Parkinson’s Disease: What’s New in PD Treatments, is now available. To access the webinar, please click the link below which will take you directly into the program. You will also be able to access the webinar slides, transcript of webinar, and APDA resources. http://www.aoic.net/APDA/APDA19359arc/ The presenters are: Marie Saint […]

Scherzer, Feany, and Dong selected for $9M Aligning Science Across Parkinson’s Initiative grant

A Brigham research team led by Clemens Scherzer, MD, director of the Center for Advanced Parkinson Research and Precision Neurology Program in the Department of Neurology, has been selected by the Aligning Science Across Parkinson’s (ASAP) initiative to receive $9 million over three years. Scherzer will lead a project titled “Parkinson5D: Deconstructing Proximal Disease Mechanisms […]

Brigham Clinical & Research News: Q&A with Dr. Clemens Scherzer

Clemens Scherzer Physician-scientist Clemens Scherzer, MD, wants to change the future of the treatment of Parkinson’s disease. In the lab, his team focuses on predicting and preventing disease progression, and on developing precision drugs and biomarkers tailored to individual patients. Scherzer is center director for the American Parkinson’s Disease Association Center for Advanced Parkinson’s Disease […]

Dr. Feany Honored with NINDS Landis Award for Outstanding Mentorship

Mel Feany, MD, PhD, from the Department of Pathology, received the 2019 Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institute of Health. The Landis Award, named in honor of former NINDS Director Story Landis, PhD, recognizes individuals who have shown dedication to mentorship and […]